Related Experiment Videos
Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in
Neera Sah1, Vimala Ramesh, Bupesh Kaul
1Department of Anesthesiology, Magee Womens Hospital and the University of Pittsburgh, Pittsburgh, PA 15213, USA. sahxnb@anes.upmc.edu
Study Objective:
To determine the efficacy of transdermal scopolamine in addition to ondansetron in decreasing the incidence of postoperative nausea and vomiting (PONV).
Design:
Randomized controlled trial.
Setting:
Academic hospital.
Patients:
126 ASA physical status I and II patients undergoing outpatient plastic surgery with three or more risk factors for PONV.
Interventions:
Patients were randomly assigned to one of two groups to receive (Group 1) a transdermal scopolamine (TDS) patch or (Group 2), a placebo patch two hours before surgery.
Measurements:
Occurrence of vomiting, severity of nausea using a visual analog scale (VAS), rescue medication, pain intensity and pain medications, and side effects were recorded every hour until discharge from hospital, then every 4 hours thereafter for a total of 24 hours.
Main Results:
A statistically significant reduction in postoperative nausea between 8 and 24 hours in patients receiving TDS was noted.
Conclusions:
Transdermal scopolamine in addition to ondansetron benefits patients at high risk for PONV undergoing outpatient plastic surgery for up to 20 hours after surgery.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Cholinergic Antagonists: Pharmacokinetics
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Transdermal Drug Delivery Systems